United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
473.66 ^USD	-0.52%		-2.41%	-2.79%

01-26	United Therapeutics Corporation Announces Positive Results from Phase 1 Study of MiroliverELAP® in Patients with Acute Liver Failure	CI
01-26	United Therapeutics Says Its Experimental Liver Assist Device Met Primary Goal in Phase 1 Study	MT

Transcript : United Therapeutics Corporation Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12

Published on 11/18/2025 at 01:35 pm GMT - Modified on 11/18/2025 at 03:37 pm GMT

S&P Capital IQ

Presenter Speech
Jiale Song (Analysts)

Welcome, everyone, to Jefferies London Healthcare Conference 2025. My name is Roger Song, one of the senior analysts cover SMid-cap biotech in the U.S. It is my

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about United Therapeutics Corporation

01-26	United Therapeutics Corporation Announces Positive Results from Phase 1 Study of MiroliverELAP® in Patients with Acute Liver Failure	CI
01-26	United Therapeutics Says Its Experimental Liver Assist Device Met Primary Goal in Phase 1 Study	MT
01-26	United Therapeutics announces positive results from phase 1 study of Miroliverelap in patients with acute liver failure	RE
01-22	United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to Board of Directors, Effective January 21, 2026	CI
01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT
01-12	United Therapeutics Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM
01-07	SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026	CI
01-06	UBS Adjusts Price Target on United Therapeutics to $645 From $600, Maintains Buy Rating	MT
01-05	United Therapeutics Insider Sold Shares Worth $500,015, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $11,572,963, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing	MT
12-23	United Therapeutics Insider Sold Shares Worth $3,047,201, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $3,952,689, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $1,742,193, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $11,166,722, According to a Recent SEC Filing	MT